Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Novo Nordisk to Spend €432 Million Expanding Irish Wegovy Production
03:25pm, Monday, 02'nd Mar 2026
Novo Nordisk (NVO) is moving decisively to reinforce its manufacturing base, announcing a â¬432 million ($507 million) investment to upgrade and retrofit its A
Novo Nordisk to Invest $506 Million in Ireland for Wegovy Production
02:45pm, Monday, 02'nd Mar 2026
Novo Nordisk (NVO, Financials) said it will invest 432 million euros, or about $506 million, to expand manufacturing capacity in Ireland as it ramps up producti
Why I'm Not Worried About Novo Nordisk Stock
12:00pm, Monday, 02'nd Mar 2026
Investors have been dumping shares of Novo Nordisk amid concerns it can't keep up with Eli Lilly. Novo Nordisk is expecting sales to decline this year, potentially by double digits.
Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly
10:57am, Monday, 02'nd Mar 2026
Novo Nordisk is investing $506 million to expand manufacturing capabilities in Ireland. The move will strengthen its ability to meet both current and future demand for its oral medicines, said Novo ex
Election of employee representatives to the Board of Directors of Novo Nordisk A/S
10:55am, Monday, 02'nd Mar 2026
Bagsværd, Denmark, 2 March 2026 – The employees in Novo Nordisk A/S have completed the election of employee representatives to the Board of Directors of Novo Nordisk A/S.
Monday's Market Movers: CRWD Rallies, NVO Downgrade, BRK/B Earnings
10:30am, Monday, 02'nd Mar 2026
As markets grapple with the U.S. and Israel joint attack on Iran, Diane King Hall turns to stock movers kicking off the new trading week. CrowdStrike's (CWRD) upgrade from Piper Sandler signals what t
Is Novo Nordisk's GLP-1 Dominance Fading After Lilly's Clinical Wins?
10:02am, Monday, 02'nd Mar 2026
NVO shares plunge 21% after Lilly's Zepbound and oral orforglipron beat its key GLP-1 drugs in head-to-head obesity and diabetes studies, respectively.
Pre-Market Stock Futures: The futures are trading lower after a dreadful Friday and week, one that could be laying the foundation for a larger and more intense sell-off. The combination of the sell-of
Novo Nordisk A/S - share repurchase programme
06:22am, Monday, 02'nd Mar 2026
Bagsværd, Denmark, 2 March 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Coun
Novo Nordisk to invest $506 million in Ireland plant expansion
04:23am, Monday, 02'nd Mar 2026
Novo Nordisk said on Monday it will invest 432 million euros ($506.43 million) to expand its manufacturing facility in Athlone, Ireland.
Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland
04:00am, Monday, 02'nd Mar 2026
The investment will support the upgrade and retrofit of the existing facility and enhance Novo Nordisk's capacity to manufacture oral GLP-1s outside the US
HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVO
04:00pm, Sunday, 01'st Mar 2026
Forward-looking guidance initially plagued Hims & Hers (HIMS) shares, says Christine Short, though she believes leadership did a good job at "refocusing" goals. She points to the company's businesses
Last week's biggest large-cap decliners, led by Novo Nordisk, First Solar and Zoom, fell on earnings misses, weak guidance and drug-pricing worries.
14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)
08:10am, Sunday, 01'st Mar 2026
March's Large Cap Value (GASV) screen highlights 14 fair-priced, 'safer' dividend stocks, including Hafnia Ltd, IRSA Inversiones, and Weibo Corp, as actionable buys. Top ten GASV stocks are projected
Weekend Morning Brew: Nvidia's Record, WBD Picks Paramount, OpenAI's $110B
07:37am, Saturday, 28'th Feb 2026
Weekly Market HighlightsMarket breadth was slightly positive with 4,817 advancers versus 4,692 decliners, but performance was highly skewed as the mean weekly
